Recent news and posts
The G-BA Innovation Committee recommends transfer to standard care for two projects in Germany
On April 4, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions which recommended the transfer to standard care for two completed projects. The projects relate to the management of rare diseases and the strengthening of the regional healthcare structures and processes.
A short overview of the projects is provided below:
- “TRANSLATE-NAMSE: better care for people living with rare diseases” project was aimed to speed up diagnosis and ensure the proper care of patients with rare congenital diseases through the coordinated collaboration of centers for rare diseases. The structures and processes proposed by NAMSE were to be introduced and sustainably implemented in nine centers for rare diseases. Through case management integrating national expertise and enabling providers to access the data from the centers involved, it was aimed to shorten the time for diagnosis and obtain the respective treatment;
- “IGIB-StimMT - Structural migration in the middle area of Templin” project aimed to adapt the regional healthcare structures and processes in the middle area of Templin to the conditions of demographic change in a needs-oriented and region-specific manner. An outpatient-inpatient center was set up in Templin for this purpose. The inpatient and outpatient care capacities were adjusted and interlinked across disciplines and institutions. This took place on several levels and included the established medical practices, the hospital, and nursing care, supplemented by establishing a coordination and advice center for individual consultations and support for patients. The project integrated outpatient, inpatient, and nursing care, as well as other health care offers.
Innovation Fund is a vital instrument to propose and test a novel model of care (including the ones in the form of selective contracts). If the model proves valuable, it can be a subject for further dissemination in the country.
The full details in German can be found here, here (TRANSLATE-NAMSE project), and here (IGIB-StimMT project).
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.